114 results
8-K
EX-99.1
JAZZ
Jazz Pharmaceuticals plc
9 Aug 23
Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance
4:07pm
by means of greater safety because Xywav provides a greatly reduced chronic sodium burden compared to Xyrem." Further, FDA stated that "the differences
8-K
EX-99.1
u5qfq5js cngspilt
10 May 23
Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance
4:08pm
8-K
EX-99.1
n8xah
3 Aug 22
Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance
4:07pm
8-K
EX-99.1
igs5y
4 May 22
Jazz Pharmaceuticals Announces First Quarter 2022
4:13pm
8-K
EX-99.1
al1dxvjglo n7toux
1 Mar 22
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2021
4:07pm
8-K
EX-99.1
j4j84fkoofj7rg
9 Nov 21
Jazz Pharmaceuticals Announces Third Quarter 2021
4:07pm
8-K
EX-99.1
76z0g
3 Aug 21
Jazz Pharmaceuticals Announces Second Quarter 2021
4:07pm